Basal Cell and Cutaneous Squamous Cell Carcinomas: Diagnosis and Treatment

被引:1
|
作者
Firnhaber, Jonathon M. [1 ]
机构
[1] East Carolina Univ, Brody Sch Med, Greenville, NC 27834 USA
关键词
PRIMARY-CARE; SKIN; MANAGEMENT; RISK;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Keratinocyte carcinoma, traditionally referred to as nonmelanoma skin cancer, includes basal cell and cutaneous squamous cell carcinoma and is the most common skin cancer malignancy found in humans. The U.S. Preventive Services Task Force recommends counseling about minimizing exposure to ultraviolet radiation for people aged six months to 24 years with fair skin types to decrease their risk of skin cancer. Routine screening for skin cancer is controversial. The U.S. Preventive Services Task Force concludes that current evidence is insufficient to assess the balance of benefits and harms of a routine whole-body skin examination to screen for skin cancer. Basal cell carcinoma commonly appears as a shiny, pearly papule with a smooth surface, rolled borders, and arborizing telangiectatic surface vessels. Cutaneous squamous cell carcinoma commonly appears as a firm, smooth, or hyperkeratotic papule or plaque, and may have central ulceration. Initial tissue sampling for diagnosis is a shave technique if the lesion is raised, or a punch biopsy of the most abnormal-appearing area of skin. High-risk factors for recurrence and metastasis include prior tumors, ill-defined borders, aggressive histologic patterns, and perineural invasion. Mohs micrographic surgery has the lowest recurrence rate among treatments but is best considered for large, high-risk tumors or tumors in sensitive anatomic locations. Smaller, lower-risk tumors are treated with surgical excision, electrodesiccation and curettage, or cryotherapy. Topical imiquimod and fluorouracil are also treatment options for superficial basal cell carcinoma and squamous cell carcinoma in situ. There are no clear guidelines for follow up after an index keratinocyte carcinoma, but monitoring for recurrence is important because the five-year risk of subsequent skin cancer is 41%. After more than one diagnosis, the five-year risk increases to 82%. Copyright (C) 2020 American Academy of Family Physicians.
引用
收藏
页码:339 / 346
页数:8
相关论文
共 50 条
  • [41] Multiple basal cell carcinomas after etanercept treatment for psoriasis
    Maire, C.
    Delesale, F.
    Carpentier, O.
    Lequint, P.
    Delaporte, E.
    Thomas, P.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2009, 136 (04): : 355 - 359
  • [42] Surgical treatment and dilemmas in the treatment of basal cell carcinomas with intracranial propagation
    Rasulic, Lukas G.
    Jovanovic, Milan D.
    VOJNOSANITETSKI PREGLED, 2014, 71 (11) : 1045 - 1048
  • [43] Multiple Synchronous Cutaneous Squamous Cell Carcinomas of the Head and Neck: A Case Report
    Ahn, John HyunBaek
    Abu-Serriah, Muammar
    Ameerally, Phillip
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2011, 69 (10) : E317 - E323
  • [44] Treatment of Unresectable and Metastatic Cutaneous Squamous Cell Carcinoma
    Cranmer, Lee D.
    Engelhardt, Candace
    Morgan, Sherif S.
    ONCOLOGIST, 2010, 15 (12) : 1320 - 1328
  • [45] Cemiplimab for the treatment of advanced cutaneous squamous cell carcinoma
    Hernandez-Guerrero, T.
    Doger, B.
    Moreno, V
    DRUGS OF TODAY, 2019, 55 (08) : 485 - 494
  • [46] MicroRNA Expression Profiling of Cutaneous Squamous Cell Carcinomas Arising in Different Sites
    Rock, Alexander N.
    Fisher, Mason D.
    Amborski, Gwenyth
    Allain, Dawn C.
    Klee, Victoria
    Peters, Sara B.
    Kang, Stephen
    Toland, Amanda E.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2020, 163 (03) : 538 - 545
  • [47] A Review of Cutaneous Squamous Cell Carcinoma Epidemiology, Diagnosis, and Management
    Kabir, Soodeh
    Schmults, Chrysalyne D.
    Ruiz, Emily S.
    INTERNATIONAL JOURNAL OF CANCER MANAGEMENT, 2018, 11 (01)
  • [48] Genetic analysis of cutaneous squamous cell carcinomas arising from different areas
    Hayashi, M
    Tamura, G
    Kato, N
    Ansai, S
    Kondo, S
    Motoyama, T
    PATHOLOGY INTERNATIONAL, 2003, 53 (09) : 602 - 607
  • [49] Efficacy of neoadjuvant cetuximab alone or with platinum salt for the treatment of unresectable advanced nonmetastatic cutaneous squamous cell carcinomas
    Reigneau, M.
    Robert, C.
    Routier, E.
    Mamelle, G.
    Moya-Plana, A.
    Tomasic, G.
    Mateus, C.
    BRITISH JOURNAL OF DERMATOLOGY, 2015, 173 (02) : 527 - 534
  • [50] Differential Expression of p-mTOR in Cutaneous Basal and Squamous Cell Carcinomas Likely Explains their Different Response to mTOR Inhibitors in Organ-transplant Recipients
    Karayannopoulou, Georgia
    Euvrard, Sylvie
    Kanitakis, Jean
    ANTICANCER RESEARCH, 2013, 33 (09) : 3711 - 3714